CEO appointed 2021
Torbjörn holds a BSc BA from IHM Business School. He has experience in leadership and international business development from both larger and smaller companies within Life Science and MedTech, including Novo Nordisk Engineering and Doxa. Experience from First North and IPO.
Holdings in the company: 40,000 shares and 40,000 warrants of series TO1
CFO appointed 2021
Anna-Lena holds a BSc BA and Economics from Stockholm University. She has experience in financing and international business in both MedTech and other industries, with senior roles such as CFO and Finance Director.
Holdings in the company: 1,400 shares and 1,400 warrants of series TO1
CTO appointed 2021
Jesper holds a MSc Chem and a PhD from Uppsala University. He has experience in product development, scale ups and commercialisation of bio-ceramic products for international markets. Experience from First North and IPO
Holdings in the company: 6,000 shares and 6,000 warrants of series TO1
Recieve press releases and reports via email.